<DOC>
	<DOCNO>NCT00208741</DOCNO>
	<brief_summary>The main purpose study determine safe effective Gabitril outpatient Social Anxiety Disorder ( SAD ) .</brief_summary>
	<brief_title>Study To Evaluate The Effects Of Gabitril™ In Patients With Social Anxiety Disorder</brief_title>
	<detailed_description>This study conduct two site United States . Approximately 50 patient , age 18 65 year old enrol Emory . This study consist two part . The first part consist 12 week open-label treatment Gabitril . If study doctor determine patient condition improve complete initial 12 week treatment may eligible second part study . This part 24-week double-blind treatment period either Gabitril placebo ( inactive medication ) . There also follow-up visit 1 3 week complete take study medication . Altogether study participation expect last approximately 37 week .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Phobic Disorders</mesh_term>
	<mesh_term>Tiagabine</mesh_term>
	<criteria>Primary diagnosis SAD CGI ( S ) ≥ 4 screen LSAS ≥ 50 baseline Covi Anxiety Scale score great Raskin depression Scale total score screen Nonresponsive adequate trial two treatment medication , previously treat SAD . HAMD ≥15 score &gt; 2 Item 1 baseline Serious unstable medical condition Alcohol substance use disorder within 6 month prior study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Social Anxiety Disorder</keyword>
	<keyword>Mental Health</keyword>
</DOC>